Clinical Trial Update: The Effects of Wellbutrin (Bupropion) on Residual and Cognitive Symptoms in SSRI-treated Depression [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial update reports the results of using bupropion (Wellbutrin) to treat residual and cognitive symptoms in patients with depression who …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Wellbutrin (bupropion)

Snippet

Sponsor: Mclean Hospital | Conditions: Depression, Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2014-08-06